Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
Phase of Trial: Phase IV
Latest Information Update: 23 Nov 2015
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 19 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 09 Sep 2015 Planned End Date changed from 1 Nov 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.